Glenmark Pharmaceuticals has entered into an agreement with Triax and Astellas to resolve a patent infringement case in the US over its generic hydrocortisone butyrate cream, used for the treatment of skin infections. The suit is related to Glenmark's filing of an abbreviated new drug application (ANDA) for 0.1% hydrocortisone butyrate cream. Hydrocortisone butyrate cream is a generic version of Triax's Locoid Lipocream.
Under the settlement and licence pact, Glenmark will be permitted to market and distribute its 0.1% hydrocortisone butyrate cream under a royalty-bearing licence from Astellas and Triax in the US near the end of 2013. Glenmark is entitled to 180 days exclusivity with respect to its cream, as it was first to file an ANDA for the product. The IMS Health data, indicates that Locoid Lipocream achieved sales of nearly $38 million in 2010.crackcrack
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1453.25 |
Dr. Reddys Lab | 5792.95 |
Cipla | 1459.85 |
Zydus Lifesciences | 1032.25 |
Lupin | 1583.95 |
View more.. |